Clinical Trial Update: Safety & Activity of P501-AS15 Vaccine as a First-line Treatment for Patients With Hormone-sensitive Prostate Cancer Who Show Rising PSA [Phase 1]

View source ↗

Summary

Phase 1 trial update showing safety and preliminary activity of the P501-AS15 vaccine as first-line therapy for hormone-sensitive prostate cancer in men with ri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• P501-AS15 Vaccine (P501-AS15 vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neoplasms, Prostate | Phase 1 | Status: COMPLETED